| Typicality: | 0.553 |
| Saliency: | 0.375 |
| currently | 10 | temporal |
| to determine their effectiveness | 6 | purpose |
| before marketing | 5 | temporal |
| drug → undergo → clinical trials | 47 |
| drug → undergo → clinical studies | 3 |
| negative | neutral | positive |
| 0.101 | 0.730 | 0.169 |
| Raw frequency | 50 |
| Normalized frequency | 0.375 |
| Modifier score | 0.940 |
| Perplexity | 54.190 |